Monteris Medical Raises $28M in Series E Funding to Expand MRI-Guided Neurosurgery Platform
Monteris Medical just pulled in $28M in Series E funding, and the signal behind that capital is louder than the number itself. When investors who live and breathe healthcare put fresh chips on the table, it usually means something real is happening in operating rooms, not just on PowerPoint slides. This round brings together InnovaHealth Partners, Birchview Capital, OSF Ventures, CU Healthcare Innovation Fund, and Madryn Asset Management. A disciplined group backing a company that has spent years turning surgical precision into a repeatable system.
To understand why that matters, rewind to Winnipeg in 1999. Dr. Mark G. Torchia and Richard Tyc looked at brain surgery and saw a problem hiding in plain sight. Opening the skull to reach deep tissue is effective, but it is also invasive, delicate, and unforgiving. Their answer became the NeuroBlate System, an MRI guided laser interstitial thermal therapy platform designed to treat brain tumors, radiation necrosis, and drug resistant epilepsy with precision heat delivered through a minimally invasive path. A small beam of energy doing very big work. Medicine has a habit of rewarding ideas that shrink the trauma while expanding the control.
Fast forward and the system now sits inside nearly 130 health systems across North America, with more than 9,000 procedures performed. Neurosurgeons are not known for adopting new toys just because they look good in a brochure. They adopt tools that give them control, visibility, and confidence when the stakes are measured in millimeters and milliseconds. NeuroBlate leans into MRI guidance and real time thermometry to make sure heat goes exactly where it should and nowhere else. In brain surgery, accuracy is not a feature. It is the whole show.
That momentum is exactly what Martin J. Emerson has been steering as CEO, with Doug Pahr keeping the financial engine humming as CFO. The new capital is aimed straight at innovation, clinical research, and expanding commercial reach across the United States and broader North America. The company is also stepping into this next chapter with a refinanced balance sheet and a new $35M credit facility with Trinity Capital, which tends to happen when performance starts whispering the word profitability.
The investor lineup tells its own story. InnovaHealth Partners and Birchview Capital returning to the table. OSF Ventures and CU Healthcare Innovation Fund reinforcing the clinical angle. Madryn Asset Management leaning further into the mission. When capital that understands healthcare keeps doubling down, it usually means the operating room is starting to look a little different than it did yesterday, and surgeons are paying attention.
